Correlation of high p95HER2:HER2 ratio with poor outcome in two phase II clinical trials of trastuzumab-treated HER2-positive metastatic breast cancer

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 34; no. 15_suppl; p. 603
Main Authors Chumsri, Saranya, Sperinde, Jeff, Liu, Heshan, Gligorov, Joseph, Spano, Jean-Philippe, Moreno-Aspitia, Alvaro, McLaughlin, Sarah A., Winslow, John William, Petropoulos, Christos J., Chenna, Ahmed, Bates, Michael Patrick, Weidler, Jodi Marie, Lie, Yolanda, Huang, Weidong, Perez, Edith A.
Format Journal Article
LanguageEnglish
Published 20.05.2016
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/JCO.2016.34.15_suppl.603